The Microliter Dosing Syringe (MDS) platform is the award-winning1, new gold standard for microliter volume injections. It can deliver a single injection of 5-150μL, and is suitable for ophthalmic injections, cell and gene therapy and other applications.
Compared to just standard syringes, it delivers more accurate, precise microliter doses, is user preferred, and shown to be easy to use2. This versatile platform incorporates standard, ISO 11040 compliant pre-fillable syringes and has a wide array of customization options.
The MDS platform is suitable for applications involving a single injection of 5 through 150 microliters.
Current standard practice is to use a milliliter dosing syringe for a microliter dose volume. Inherent in this approach is inaccurate, imprecise microliter injection volume. Larger volume syringes are also not suitable for injection of viscous formulations. Lack of resolution results in poor user control, and hence results in significant drug waste. The MDS addresses these needs.
One key area where these issues converge is ophthalmology. Congruence’s MDS can be used to address these needs, and can deliver a variety of drugs (such as anti-VEGF) via several routes including Intravitreal, Subretinal, Subtenon, Suprachoroidal and Intracameral.
Other applications include Localized delivery, Cell & Gene Therapies, Long-acting formulations and Potent therapeutics, as well as various others.
Additional data available upon request